KA

Kenneth Attie

EVP and Chief Medical Officer

Versanis Bio

Boston, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Versanis Bio
Industry
biotechnology
Employees
11.0
Seniority
C suite
Annual Revenue
2100000.0
Total Funding
70000000.0
Latest Funding
Series A

Technologies

Outlook Microsoft Office 365 Amazon AWS Remote AI

Keywords

obesity cardiometabolic diseases activin biology incretin biology transformative treatments fat metabolism muscle metabolism visceral fat clinical research patient safety clinical trials medicines insulin access programs diabetes treatment cancer treatment immunology pain management alzheimer's disease innovative therapies research & development health outcomes drug development gene therapy patient support sustainability corporate social responsibility cross-cultural marketing diversity & inclusion lilly foundation medication safety chronic diseases functional cures healthcare innovations clinical trial access patient assistance programs community engagement healthcare partnerships quality of life improvements pharmaceutical manufacturing global health initiatives diabetes management cancer therapies personalized medicine neurodegenerative diseases chronic conditions health equity pharmaceutical collaborations experimental medicines health care health wellness & fitness hospital & health care environmental services renewables & environment pharmaceuticals medical

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans